Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Health Care Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Teva Pharmaceutical Industries ( TEVA) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 0.5%. By the end of trading, Teva Pharmaceutical Industries rose $1.07 (2.3%) to $46.74 on heavy volume. Throughout the day, 11,427,441 shares of Teva Pharmaceutical Industries exchanged hands as compared to its average daily volume of 6,051,400 shares. The stock ranged in a price between $45.37-$47.79 after having opened the day at $45.37 as compared to the previous trading day's close of $45.67. Other companies within the Health Care sector that increased today were: Dehaier Medical Systems ( DHRM), up 34.6%, Chelsea Therapeutics International ( CHTP), up 24.4%, Tianyin Pharmaceutical ( TPI), up 22.2% and Oculus Innovative ( OCLS), up 20.6%.

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes pharmaceutical products worldwide. Teva Pharmaceutical Industries has a market cap of $41.8 billion and is part of the drugs industry. Shares are up 10.2% year to date as of the close of trading on Tuesday. Currently there are 5 analysts that rate Teva Pharmaceutical Industries a buy, 3 analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates Teva Pharmaceutical Industries as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in net income, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.

On the negative front, NeoGenomics ( NEO), down 15.3%, Prana Biotechnology ( PRAN), down 13.3%, Escalon Medical Corporation ( ESMC), down 10.3% and Alphatec Holdings ( ATEC), down 9.1% , were all laggards within the health care sector with Merck ( MRK) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Novartis May Sell U.S. Generic Pill Business Amid Industry Struggles

Novartis May Sell U.S. Generic Pill Business Amid Industry Struggles

Five-Day Winning Streak in Stocks Expected to Continue

Five-Day Winning Streak in Stocks Expected to Continue

Dow Jumps Over 300 Points, Posting Its Fifth Straight Day of Gains

Dow Jumps Over 300 Points, Posting Its Fifth Straight Day of Gains

Stock Markets Around the World Are Soaring Again

Stock Markets Around the World Are Soaring Again

Jim Cramer: The SEC Should Admit It Goofed With These Crazy Instruments

Jim Cramer: The SEC Should Admit It Goofed With These Crazy Instruments